Pen needles, as compared to traditional syringes and vials, provide a convenient, easier and more accurate dosage. Such needles do not require to be pushed through the rubber vial stopper and thus tend to retain their sharpness and lubrication. Such needles, on account of accidental strokes, possess a high risk of secondary infections, which can be reduced by the use of pen needles. Thus, this market possesses a lucrative potential.
Insulin pens are the most convenient and fastest mode of injecting drug delivery. Pen needles are highly demanded in conjunction with growing need for insulin pens for people suffering from diabetes. These devices used with insulin pens help in delivering the dosage of the drug to the patient.
Request Exclusive Free Sample of Pen Needles Market Report @ https://dataintelo.com/request-sample/?reportId=551
Insulin pens coupled with needles are considered as an improved alternative drug delivery process in comparison to syringes and vials. Traditional syringes are large and create difficulty in self-administration. However, pen needles have fine pointed tips, which helps in easy penetration into the patient's muscle. These needles also facilitate safety pertaining to insulin delivery amongst diabetic patients.
The global pen needles market was valued at USD 1.5 billion in 2015, which is projected to grow at a CAGR of more than 13.0% during the forecast period.
According to the WHO, in 2014, 422 million people had diabetes and it is estimated that it would be the 7th leading cause of death in 2030.
Co. UK, obesity accounts for 80% to 85% chances of developing type 2 diabetes.
Short length pen needles can be easily used by everyone including overweight, children, and the patient with phobia of needles.
For instance, in 2014, Novo Nordisk made NovoFine Plus, the thinnest and shortest needle commercially available in the U.S.
It does not offer resistance while injecting and provides greater comfort as compared to other injections.
